Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Vasilis Ntziachristos, Carolien P. Schröder et al.|Cancer Research|2016Cited by 43
Fluorescently labeled bevacizumab in human breast cancer: defining the classification thresholdMaximilian Koch, Vasilis Ntziachristos, Johannes S. de Jong et al.|Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE|2017Cited by 0
Supplemental Materials and Methods and Supplementary Figures 1 and 2 from Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Vasilis Ntziachristos, Johannes S. de Jong et al.|Unknown|2023Cited by 0
Supplemental Materials and Methods and Supplementary Figures 1 and 2 from Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Vasilis Ntziachristos, Johannes S. de Jong et al.|Unknown|2023Cited by 0
Data from Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Vasilis Ntziachristos, Johannes S. de Jong et al.|Unknown|2023Cited by 0